TWST earnings / call / takeaways

TWST Q4 FY26 earnings call: key takeaways

What TWST said on its earnings call of November 12, 2026: results against expectations, what changed since last quarter, guidance and the questions analysts pressed on.

By Lician·November 12, 2026·AI-generated from the call transcript and Lician data

Revenue grew 28% to $126.6 million in Q4, driven by AI drug discovery (12:31)
Outlook: full-year revenue of $550 million to $560 million (35:55)

Results vs expectations

Metric	Consensus	Reported	Result
EPS	-$0.43	–	–

What changed since last quarter

The company raised full-year revenue guidance to $550 million to $560 million, representing 21% growth, up from previous expectations. (35:55)
TWIST increased capital expenditures to $75 million to $100 million for fiscal 2027, focusing on capacity and automation. (37:49)
The CEO emphasized the need to expand capacity to meet demand, citing the importance of keeping ahead of customer demand. (26:46)

Guidance

Metric	This call	Previous call
Revenue	Full-year revenue of $550 million to $560 million (35:55)	not captured
Revenue	AI drug discovery revenue of $100 million (35:55)	not captured

What analysts pressed on

Whether the growth in AI drug discovery will moderate due to increased competition and market saturation. (41:25)
How the company plans to handle the transition of traditional pharma customers to AI-driven workflows. (51:10)
Concerns about the impact of new capacity investments on gross margins in the short term. (1:09:56)

In their words

We are building the infrastructure for that future. Emily Leproust (38:47)
We have the platform, the people, and the capital to lead. Emily Leproust (40:38)

Read the full transcript with the AI summary, or listen on the company's official webcast.

Every past call in full and transcript search come with Lician Pro.

Written by AI from the automatic transcript of the company's public webcast and Lician's earnings data. Each sentence cites the passage it comes from, and a sentence with a figure that is not in its sources was removed. Not investment advice.